应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IL IntraLinks Holdings
退市 03-31 14:29:43 EDT
13.01
+0.00
0.00%
最高
13.01
最低
13.01
成交量
0.00
今开
13.01
昨收
13.01
日振幅
0.00%
总市值
7.55亿
流通市值
5.23亿
总股本
5,802万
成交额
0.00
换手率
0.00%
流通股本
4,020万
市净率
2.85
ROE
--
每股收益
-0.35
52周最高
13.72
52周最低
6.22
市盈率
-37.17
股息
0.00
股息收益率
0.00
ROA
--
分时
五日
日K
周K
月K
暂无数据
北京优虎网络科技有限公司
资讯
新帖
简况
三生国健(688336.SH)重组抗IL-4Rα人源化单克隆抗体注射液获得药物临床试验批准通知书
智通财经 · 2023-04-14
三生国健(688336.SH)重组抗IL-4Rα人源化单克隆抗体注射液获得药物临床试验批准通知书
加载更多
公司概况
公司名称:
IntraLinks Holdings
所属市场:
NYSE
上市日期:
2010-08-06
主营业务:
Intralinks Holdings, Inc.以Intralinks公司之名于1996年6月组成于特拉华州。2007年6月完成合并,Intralinks公司随后成为了TA Indigo控股公司的全资子公司。TA Indigo控股公司位于特拉华州,是TA 联合公司所有的新成立的公司,现在已经是TA 联合管理股份有限公司、Intralinks公司某些持股公司(包括Rho资金合伙企业以及Intralinks公司曾经和现在的员工)的一部分。合并是根据美国公认会计准则(GAAP)在购入记账法的原则下完成的。2010年,公司将TA Indigo控股公司更名为Intralinks控股公司。
发行价格:
13.00
{"stockData":{"symbol":"IL","market":"US","secType":"STK","nameCN":"IntraLinks Holdings","latestPrice":13.01,"timestamp":1575925200000,"preClose":13.01,"halted":4,"volume":0,"delay":0,"floatShares":40200000,"shares":58020000,"eps":-0.35,"marketStatus":"退市","change":0,"latestTime":"03-31 14:29:41 EDT","open":13.01,"high":13.01,"low":13.01,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.35,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1743451200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1281067200000,"exchange":"NYSE","adjPreClose":13.01,"volumeRatio":0},"requestUrl":"/m/hq/s/IL","defaultTab":"news","newsList":[{"id":"2327423112","title":"三生国健(688336.SH)重组抗IL-4Rα人源化单克隆抗体注射液获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2327423112","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2327423112?lang=zh_cn&edition=full","pubTime":"2023-04-14 15:42","pubTimestamp":1681458128,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三生国健 公告,公司重组抗IL-4Rα人源化单克隆抗体注射液收到国家药品监督管理局核准签发的慢性鼻窦炎伴鼻息肉临床试验《药物临床试验批准通知书》,目前SSGJ-611在中国中重度特应性皮炎受试者中开展的一项II期临床研究已完成全部患者入组,并将于近期开展慢性鼻窦炎伴鼻息肉适应症的II期临床试验。据悉,SSGJ-611产品是公司创新研发,拥有自主知识产权的人源化抗IL-4Rα单克隆抗体,具有全新的氨基酸序列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/910582.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","688336","BK1583","BK1576","BK0239","IL","03347"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.intralinks.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0148},{"period":"1month","weight":-0.0654},{"period":"3month","weight":-0.0661},{"period":"6month","weight":-0.0277},{"period":"1year","weight":0.0623},{"period":"ytd","weight":-0.0519}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Intralinks Holdings, Inc.以Intralinks公司之名于1996年6月组成于特拉华州。2007年6月完成合并,Intralinks公司随后成为了TA Indigo控股公司的全资子公司。TA Indigo控股公司位于特拉华州,是TA 联合公司所有的新成立的公司,现在已经是TA 联合管理股份有限公司、Intralinks公司某些持股公司(包括Rho资金合伙企业以及Intralinks公司曾经和现在的员工)的一部分。合并是根据美国公认会计准则(GAAP)在购入记账法的原则下完成的。2010年,公司将TA Indigo控股公司更名为Intralinks控股公司。","exchange":"NYSE","name":"IntraLinks Holdings","nameEN":"IntraLinks"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IntraLinks Holdings(IL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供IntraLinks Holdings(IL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"IntraLinks Holdings,IL,IntraLinks Holdings股票,IntraLinks Holdings股票老虎,IntraLinks Holdings股票老虎国际,IntraLinks Holdings行情,IntraLinks Holdings股票行情,IntraLinks Holdings股价,IntraLinks Holdings股市,IntraLinks Holdings股票价格,IntraLinks Holdings股票交易,IntraLinks Holdings股票购买,IntraLinks Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IntraLinks Holdings(IL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供IntraLinks Holdings(IL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}